The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Oxidative Stress in Cancer Cell Metabolism
Open accessAbstract
Reactive oxygen species (ROS) are important in regulating normal cellular processes whereas deregulated ROS leads to the development of a diseased state in humans including cancers. Several studies have been found to be marked with increased ROS production which activates pro-tumorigenic signaling, enhances cell survival and proliferation and drives DNA damage and genetic instability. However, higher ROS levels have been found to promote anti-tumorigenic signaling by initiating oxidative stress-induced tumor cell death. Tumor cells develop a mechanism where they adjust to the high ROS by expressing elevated levels of antioxidant proteins to detoxify them while maintaining pro-tumorigenic signaling and resistance to apoptosis. Therefore, ROS manipulation can be a potential target for cancer therapies as cancer cells present an altered redox balance in comparison to their normal counterparts. In this review, we aim to provide an overview of the generation and sources of ROS within tumor cells, ROS-associated signaling pathways, their regulation by antioxidant defense systems, as well as the effect of elevated ROS production in tumor progression. It will provide an insight into how pro- and anti-tumorigenic ROS signaling pathways could be manipulated during the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–230 of 230
PIG3: A novel link between oxidative stress and DNA damage response in cancer
Kotsinas, A., Aggarwal, V., Tan, E.-J., Levy, B., & Gorgoulis, V. G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.009 · Cited by 65
Song, J., Li, J., Lulla, A., Evers, B. M., & Chung, D. H. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00486.2005 · Cited by 61
Fortunato, F. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1025 · Cited by 60
ASK Family Proteins in Stress Response and Disease
Fujisawa, T., Takeda, K., & Ichijo, H. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0053-x · Cited by 60
Gdynia, G., Keith, M., Kopitz, J., Bergmann, M., Fassl, A., Weber, A. N. R., George, J., Kees, T., Zentgraf, H.-W., Wiestler, O. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0204 · Cited by 59
NF-κB Signaling: An ALternate Pathway for Oxidate Stress Responses
Störz, P., & Toker, A. (2003) · Cell Cycle · doi:10.4161/cc.2.1.234 · Cited by 59
Role of polyunsaturated fatty acids and lipid peroxidation on colorectal cancer risk and treatments
Cai, F., Dupertuis, Y. M., & Pichard, C. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834feab4 · Cited by 57
Ceylan‐Isik, A. F., Guo, K. K., Carlson, E. C., Privratsky, J. R., Liao, S.-J., Cai, L. F., Chen, A. F., & Ren, J. T. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123422 · Cited by 57
Autophagy: novel action of panitumumab in colon cancer.
Giannopoulou, E., Antonacopoulou, A. G., Matsouka, P., & Kalofonos, H. P. (2009) · PubMed · Cited by 56
Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
Marchetti, M. A., Resnick, L., Gamliel, E., Kesaraju, S., Weissbach, H., & Binninger, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005804 · Cited by 56
Peeters, M., BALFOUR, J., & Arnold, D. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03717.x · Cited by 56
Luo, Y., Sun, X., Huang, L., Yan, J. C., Yu, B., & Tian, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b07390 · Cited by 55
Wang, H., Wang, L., Li, N., Li, J., Feng, Y., Zhao, Y., Wang, L., Yi, J., Wang, L., Bian, J., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/851692 · Cited by 51
Lü, C., & Armstrong, J. S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.196 · Cited by 50
Allegra, A., Pioggia, G., Tonacci, A., Casciaro, M., Musolino, C., & Gangemi, S. (2020) · Antioxidants · doi:10.3390/antiox9111037 · Cited by 47
Essential Role of DNA Base Excision Repair on Survival in an Acidic Tumor Microenvironment
Seo, Y., & Kinsella, T. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0624 · Cited by 46
Li, Q., Yin, X., Wang, W. T., Zhan, M., Zhao, B., Hou, Z., & Wang, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3879 · Cited by 44
Ramírez, L. V., Ramírez-Tortosa, M. C., Pérez-López, P., Granados-Principal, S. M., Battino, M. A., & Quiles, J. L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.029 · Cited by 41
Targeted therapy for lung cancer: present and future.
Aggarwal, C. (2014) · PubMed · doi:10.3978/j.issn.2224-5820.2014.06.01 · Cited by 39
Ahmad, I. M., Abdalla, M. Y., Aykin‐Burns, N., Simons, A. L., Oberley, L. W., Domann, F. E., & Spitz, D. R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.007 · Cited by 37
Yao, Z., Liu, N., Zhu, X., Wang, L., Zhao, Y., Liu, Q., Gao, C., & Li, J. (2020) · Aging · doi:10.18632/aging.202349 · Cited by 36
Doroshow, J. H., Juhasz, A. N., Ge, Y., Holbeck, S. L., Lu, J., Antony, S., Wu, Y., Jiang, G., & Roy, K. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.022 · Cited by 35
Indran, I. R., Hande, M. P., & Pervaiz, S. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.001 · Cited by 33
Perri, M., Pingitore, A., Cione, E., E, V., Perrone, V., & Genchi, G. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.06.006 · Cited by 33
Miller, C. M., O’Sullivan, E. C., & McCarthy, F. O. (2019) · Pharmaceuticals · doi:10.3390/ph12020090 · Cited by 28
Genetic Interactions of STAT3 and Anticancer Drug Development
Fang, B. (2014) · Cancers · doi:10.3390/cancers6010494 · Cited by 27
Yen, C.-J., Hung, C., Tsai, W.-M., Cheng, H.-C., Yang, H.-L., Lu, Y.-J., & Tsai, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01536 · Cited by 27
Saleem, M. Z., Alshwmi, M., Zhang, H., Din, S. R. U., Nisar, M. A., Khan, M. N., Alam, S., Alam, G., Jin, L., & Ma, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01055 · Cited by 25
Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells
Bustamante, J., Galleano, M., Medrano, E. E., & BOVERIS, A. (1990) · Breast Cancer Research and Treatment · doi:10.1007/bf01806295 · Cited by 21
Russell, E. G., Guo, J., O’Sullivan, E. C., O’Driscoll, C. M., McCarthy, F. O., & Cotter, T. G. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0302-y · Cited by 21
Cited by
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
Oxidative cell death in cancer: mechanisms and therapeutic opportunities
An, X., Yu, W., Liu, J., Tang, D., Yang, L., & Chen, X. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06939-5 · Cited by 523
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Defect Engineering in Nanocatalysts: From Design and Synthesis to Applications
Muhammad, P., Zada, A., Rashid, J., Hanif, S., Gao, Y., Li, C., Li, Y., Fan, K., & Wang, Y. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202314686 · Cited by 350
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Metadata
- Authors
- Arfin, S., Jha, N. K., Jha, S. K., Kesari, K. K., Ruokolainen, J., Roychoudhury, S., Rathi, B., & Kumar, D.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-04-22
- Volume
- 10
- Issue
- 5
- Pages
- 642
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W3153831334
- Cited by
- 665
- References
- 230
- FWCI
- 27.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.